Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The study hypothesis is that chemoradiation based on 2 drugs will improve local control and long-term survival in patients with locally advanced pancreatic cancer. That is why gemcitabine and irinotecan are combined in an induction phase of 2 months and then this IrinoGem combination is given for 3 more cycles, in reduced doses,concurently with irradiation.
Epistemonikos ID: a6a9416ee37de0e7b051d0af2102f7ce74e50322
First added on: May 04, 2024